Published 1 day ago • loading... • Updated 1 day ago

Study Finds NuLiv Science Ingredient, AstraGin®, Supports Intestinal Barrier Integrity and Probiotic Adhesion

On Jan. 27, 2026, NuLiv Science announced from BREA, Calif. a preclinical AstraGin study published in Bioactive Compounds in Health and Disease reporting intestinal barrier improvements.
Richard Wang, CEO of NuLiv Science, said that the study reinforces earlier human research reporting increases in beneficial gut bacteria with AstraGin.
Lab assays showed researchers assessed barrier integrity, cellular energy, and probiotic activity using established in‑vitro markers, with AstraGin increasing TEER and restoring tight junction proteins.
For brands formulating gut‑health products, the study authors concluded AstraGin demonstrated protective effects against LPS‑induced inflammation and may be considered a functional food ingredient.
The findings suggest AstraGin may be considered a functional food ingredient that enhanced Lactobacillus rhamnosus growth and adhesion in inflammatory conditions simulated by LPS, supporting gut health markers.

Insights by Ground AI

18 Articles

Helena Independent Record

+17 Reposted by 17 other sources

Center

Study Finds NuLiv Science Ingredient, AstraGin®, Supports Intestinal Barrier Integrity and Probiotic Adhesion

BREA, Calif., Jan. 27, 2026 /PRNewswire/ -- NuLiv Science, a leading plant-based nutraceutical ingredients company enabling people to lead healthier lives, announced the release of a new preclinical study evaluating the effects of AstraGin®, its patented compound derived from Astragalus…

1 day ago·Helena, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year